<VariationArchive VariationID="977280" VariationName="NM_001204077.2(UBE4A):c.1217_1218del (p.Cys406fs)" VariationType="Deletion" Accession="VCV000977280" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-07" DateCreated="2020-08-29" MostRecentSubmission="2021-12-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965409" VariationID="977280">
      <GeneList>
        <Gene Symbol="UBE4A" FullName="ubiquitination factor E4A" GeneID="9354" HGNC_ID="HGNC:12499" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118359600" stop="118399211" display_start="118359600" display_stop="118399211" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118230295" stop="118269925" display_start="118230295" display_stop="118269925" Strand="+" />
          </Location>
          <OMIM>603753</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001204077.2(UBE4A):c.1217_1218del (p.Cys406fs)</Name>
      <CanonicalSPDI>NC_000011.10:118374994:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118374995" stop="118374996" display_start="118374995" display_stop="118374996" variantLength="2" positionVCF="118374994" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118245710" stop="118245711" display_start="118245710" display_stop="118245711" variantLength="2" positionVCF="118245709" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C406fs</ProteinChange>
      <ProteinChange>C413fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.118374996_118374997del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.118374996_118374997del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118245711_118245712del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118245711_118245712del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_047106.1" sequenceAccession="NG_047106" sequenceVersion="1" change="g.20416_20417del">
            <Expression>NG_047106.1:g.20416_20417del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204077.2" sequenceAccession="NM_001204077" sequenceVersion="2" change="c.1217_1218del" MANESelect="true">
            <Expression>NM_001204077.2:c.1217_1218del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001191006.1" sequenceAccession="NP_001191006" sequenceVersion="1" change="p.Cys406fs">
            <Expression>NP_001191006.1:p.Cys406fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004788.4" sequenceAccession="NM_004788" sequenceVersion="4" change="c.1238_1239del">
            <Expression>NM_004788.4:c.1238_1239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004779.2" sequenceAccession="NP_004779" sequenceVersion="2" change="p.Cys413fs">
            <Expression>NP_004779.2:p.Cys413fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603753.0002" DB="OMIM" />
        <XRef Type="rs" ID="1948638548" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001204077.2(UBE4A):c.1217_1218del (p.Cys406fs) AND not specified" Accession="RCV001254871" Version="3">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-12-07" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001204077.2(UBE4A):c.1217_1218del (p.Cys406fs) AND Neurodevelopmental disorder with hypotonia and gross motor and speech delay" Accession="RCV001787127" Version="1">
        <ClassifiedConditionList TraitSetID="71155">
          <ClassifiedCondition DB="MedGen" ID="C5562031">Neurodevelopmental disorder with hypotonia and gross motor and speech delay</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-08-29" MostRecentSubmission="2021-12-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">33420346</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2021-12-04">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="71155" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="60958" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with hypotonia and gross motor and speech delay</ElementValue>
                <XRef ID="MONDO:0859207" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDHMS</ElementValue>
                <XRef Type="MIM" ID="619639" DB="OMIM" />
              </Symbol>
              <XRef ID="C5562031" DB="MedGen" />
              <XRef ID="MONDO:0859207" DB="MONDO" />
              <XRef Type="MIM" ID="619639" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2825899" SubmissionDate="2020-08-27" DateLastUpdated="2020-08-29" DateCreated="2020-08-29">
        <ClinVarSubmissionID localKey="SUB7897809" submittedAssembly="GRCh37" title="SUB7897809" />
        <ClinVarAccession Accession="SCV001427244" DateUpdated="2020-08-29" DateCreated="2020-08-29" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Stanford Medicine" OrgID="507411" OrganizationCategory="laboratory" OrgAbbreviation="CGP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The p.Cys413Phefs*55 variant in the UBE4A gene has not been previously reported in association with disease. Homozygosity of the variant segregates with disease in the patientâ€™s family. The variant was absent from large population databases, including the Genome Aggregation Database(http://gnomad.broadinstitute.org/). The p.Cys413Phefs*55 variant results in 2bp deletion, which causes a shift in the protein reading frame, leading to a premature termination codon 55 amino acids downstream. Loss of function is the proposed mechanism of disease for the UBE4A related disorder. These data were assessed using the ACMG/AMP variation interpretation guidelines. In summary, the significance of the p.Cys413Phefs*55 variant is uncertain,in part due to the preliminary disease association. Additional information is needed to resolve the significance of this variant.[ACMG evidence codes used: PVS1_moderate, PM2, PP1]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UBE4A">
              <Name>ubiquitination factor E4A</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Cys413Phefs*55</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004788.3:c.1238_1239delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7897809</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3981749" SubmissionDate="2021-12-01" DateLastUpdated="2021-12-04" DateCreated="2021-12-04">
        <ClinVarSubmissionID localKey="603753.0002_NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY" title="UBE4A, 2-BP DEL, 1238GT_NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY" />
        <ClinVarAccession Accession="SCV002029070" DateUpdated="2021-12-04" DateCreated="2021-12-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 sibs, born of consanguineous Hispanic parents (family B), with neurodevelopmental disorder with hypotonia and gross motor and speech delay (NEDHMS; 619639), Melo et al. (2021) identified a homozygous 2-bp deletion (c.1238_1239delGT, NM_004788.3) in exon 9 of the UBE4A gene, resulting in a frameshift and premature termination (Cys413PhefsTer55). The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. There were no homozygous loss-of-function mutations in the UBE4A gene in the gnomAD database. Functional studies of the variant and studies of patient cells were not performed, but the variant was predicted to result in a complete loss of protein function.</Attribute>
              <Citation>
                <ID Source="PubMed">33420346</ID>
              </Citation>
              <XRef DB="OMIM" ID="619639" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UBE4A" />
          </GeneList>
          <Name>UBE4A, 2-BP DEL, 1238GT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 1238GT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603753.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3981749" TraitType="Disease" MappingType="Name" MappingValue="NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY" MappingRef="Preferred">
        <MedGen CUI="C5562031" Name="Neurodevelopmental disorder with hypotonia and gross motor and speech delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2825899" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

